Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dementia
Investigators at University of California have published new data on dementia
November 19th, 2007
"Few studies have compared the accuracy of [F-18] fluorodeoxyglucose (FDG) PET to the accuracy of clinical and pathologic diagnosis in dementia patients Forty-four individuals with dementia, cognitive impairment, or normal cognitive function underwent clinical initial evaluation (IE) and PET scanning and were followed up for approximately 4 years until a final evaluation (FE) and 5 years until death and autopsy. Clinical, pathologic, and imaging diagnoses were categorized as Alzheimer disease (AD) or not AD Sensitivity of the IE for the pathologic diagnosis of AD was 0.76, and specificity was 0.58; PET had values of 0.84 and 0.74, and FE had values of 0.88 and 0.63," scientists writing in...
Source: Pain & Central Nervous System Week (2007-11-19)
|
|
Advertisement |
|
|
|
